Stevanato Group S.p.A (STVN) Cash from Investing Activities (2020 - 2026)

Stevanato Group S.p.A's (STVN) quarterly Cash from Investing Activities came in at -$82.4 million in Q1 2026, down 10.81% year-on-year from -$92.4 million in Q1 2025, and up 24.96% on a QoQ basis from -$109.8 million in Q4 2025.

Stevanato Group S.p.A (STVN) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has 7 years of Cash from Investing Activities data on file, last reported at -$82.4 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 10.81% year-over-year to -$82.4 million in Q1 2026; TTM through Mar 2026 was -$316.1 million, a 5.82% decrease from a year earlier, with the FY2025 full-year figure at -$317.7 million, up 4.16% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$82.4 million, up from -$109.8 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for STVN reached as high as -$43.6 million in Q3 2022 and fell as low as -$143.9 million in Q3 2023.
  • Historically, Cash from Investing Activities has averaged -$85.5 million across 5 years, with a median of -$81.3 million in 2022.
  • Across the five-year window, Cash from Investing Activities tumbled 230.4% in 2023 and jumped 63.7% in 2024, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$70.2 million in 2022, then slumped by 41.45% to -$99.3 million in 2023, then increased by 2.03% to -$97.3 million in 2024, then retreated by 12.91% to -$109.8 million in 2025, then increased by 24.96% to -$82.4 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$82.4 million in Q1 2026, -$109.8 million in Q4 2025, and -$56.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Intuitive Surgical 126.54 Bn 121.33 Bn 1.96 Bn -26.60 Mn
2 Becton Dickinson 44.82 Bn 44.00 Bn 2.15 Bn -139.00 Mn
3 Alcon 32.93 Bn 31.28 Bn 1.53 Bn -218.00 Mn
4 Medline 32.92 Bn 30.68 Bn 1.84 Bn -96.00 Mn
5 Resmed 29.48 Bn 27.82 Bn 890.98 Mn -58.03 Mn
6 West Pharmaceutical Services 23.40 Bn 22.97 Bn 329.20 Mn -43.20 Mn
7 Solventum 14.04 Bn 13.48 Bn 1.10 Bn -77.00 Mn
8 Cooper Companies 13.79 Bn 13.65 Bn 735.40 Mn -90.00 Mn
9 Align Technology 12.05 Bn 10.99 Bn 736.59 Mn -131.58 Mn
10 Stevanato Group S.p.A 5.43 Bn 5.28 Bn 88.01 Mn -82.42 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -82.42 Mn
Mar 31, 2026 -82.42 Mn
Dec 31, 2025 -109.83 Mn
Dec 31, 2025 -109.83 Mn
Sep 30, 2025 -56.34 Mn
Sep 30, 2025 -56.34 Mn
Jun 30, 2025 -67.53 Mn
Jun 30, 2025 -67.53 Mn
Mar 31, 2025 -74.38 Mn
Mar 31, 2025 -74.38 Mn
Dec 31, 2024 -97.28 Mn
Dec 31, 2024 -97.28 Mn
Sep 30, 2024 -52.24 Mn
Sep 30, 2024 -52.24 Mn
Jun 30, 2024 -74.84 Mn
Jun 30, 2024 -74.84 Mn
Mar 31, 2024 -110.93 Mn
Mar 31, 2024 -110.93 Mn
Dec 31, 2023 -99.29 Mn
Dec 31, 2023 -99.29 Mn